Inactive Instrument

Cornerstone Therapeutics, Inc. Share Price

Stocks

End-of-day quote Nasdaq
- ^USD	-

28/14/28	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Inc. Stockholders Approve Merger	PU
04/14/04	Cornerstone Therapeutics Inc. Stockholders Approve Merger	MW
01/14/01	Cornerstone Therapeutics Adjourns Special Meeting of Stockholders	MW
20/13/20	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Launches BETHKIS(R) (Tobramycin Inhalation Solution) for Management of Cystic Fibrosis Patients With Pseudomonas Aeruginosa	PU
01/13/01	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics to Host Third Quarter 2013 Conference Call	PU

16/13/16	USA-Les valeurs à suivre à Wall Street (actualisé)
16/13/16	USA-Les valeurs à suivre à Wall Street (actualisé)

Manager	Title	Age	Since
Jon Zwinski CEO	Chief Executive Officer	-	01/01/2021
William James Alexander CTO	Chief Tech/Sci/R&D Officer	76	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	-0.77%	-1.65%	+15.84%	+62.32%	4.64TCr
OTSUKA HOLDINGS CO., LTD.	+2.12%	+2.49%	+46.00%	+112.97%	3.73TCr
ZYDUS LIFESCIENCES LIMITED	+0.92%	+4.65%	+24.62%	+101.58%	1.25TCr
CIPLA LIMITED	-1.14%	-0.17%	-7.72%	+18.87%	1.18TCr
KRKA, D. D.	+0.19%	+0.19%	+17.87%	+137.90%	897.09Cr
ONO PHARMACEUTICAL CO., LTD.	-0.87%	-2.43%	+38.79%	-18.10%	729.19Cr
GEDEON RICHTER	-0.64%	-3.88%	+26.92%	+38.16%	709.04Cr
GLENMARK PHARMACEUTICALS LIMITED	-2.28%	-5.07%	+17.95%	+199.34%	700.76Cr
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-1.19%	-4.87%	-50.77%	+0.71%	498.93Cr
Average	-0.41%	-0.27%	+14.39%	+72.64%	1.59TCr
Weighted average by Cap.	+0.07%	+0.41%	+22.14%	+79.34%

Employees

Sector